# FDA recall D-1872-2019

> **Aurolife Pharma, LLC** · Class II · drug recall initiated 2019-08-23.

## Product

Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 30-count bottles, Distributed by: Aurohealth LLC, 2572 Brunswick Pike, Lawrenceville, NJ  08648; NDC 58602-820-09.

## Reason for recall

Failed Impurities/Degradation Specifications

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-1872-2019
- **Recalling firm:** Aurolife Pharma, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-08-23
- **Report date:** 2019-09-25
- **Termination date:** 2022-08-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Dayton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1872-2019

## Citation

> AI Analytics. FDA recall D-1872-2019. Retrieved 2026-06-13 from https://api.ai-analytics.org/recall/D-1872-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*